ReviewHematology/oncology clinics of North America2020

Targeting Aberrant Splicing in Myelodysplastic Syndromes: Biologic Rationale and Clinical Opportunity.

Andrew M Brunner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.